Drugs & OTC

Anatara Lifesciences Ltd (ASX:ANR) Partnering Update

🕔6/23/2020 1:04:50 PM

Anatara is nearing conclusion of a process of due diligence and negotiation with many of the world's leading animal health companies. Anatara's objective being to partner with a company or companies to register Detach(R) in key overseas markets.

Read Full Article

Cann Global Limited (ASX:CGB) Research Results Lead to Broader Auto-immune Research

🕔6/15/2020 10:11:11 AM

Cann Global Limited's (ASX:CGB) medical Cannabis research division, Medical Cannabis Research Group Pty Ltd (MCRG) entered into a research agreement to research the possibility of the use of cannabis in the treatment of autoimmune disease, specifically multiple sclerosis (MS).

Read Full Article

Cann Global Limited (ASX:CGB) Cann Global Asia Update

🕔6/15/2020 9:36:50 AM

The Board of Cann Global Limited (ASX:CGB) wishes to update our shareholders on the operations of its 55% owned subsidiary Cann Global Asia Pty Ltd, and its activities in Laos PDR.

Read Full Article

Cann Global Limited (ASX:CGB) Replacement March 2020 Quarterly Activities Report

🕔5/5/2020 8:28:45 AM

On 30 April 2020, Cann Global Ltd (ASX:CGB) lodged the Company's quarterly activities and cashflow reports for the period ended 31 March 2020. This amendment includes an updated cashflow report.

Read Full Article

Cann Global Limited (ASX:CGB) Quarterly Activities Report

🕔5/1/2020 8:14:25 AM

In October 2019, Austrade published a report on Australia's food innovators which Cann Global Limited (ASX:CGB), through its subsidiaries T12 and HHC, is very excited to be a part of.

Read Full Article

US and UK Investors Reach Out to Labat Africa Ltd (JSE:LAB) as the South African Group Advances Into Major Medical Cannabis and CBD Markets

🕔4/28/2020 1:43:35 PM

The South African group, Labat Africa Ltd (JSE:LAB) which announced last year it was entering the medical CANNABIS market, is gaining the interest of High net worth and institutional investors in London and New York.

Read Full Article

Anatara Lifesciences Ltd (ASX:ANR) Appendix 4C - Quarterly

🕔4/27/2020 10:02:06 AM

Anatara Lifesciences Ltd (ASX:ANR) is pleased to release its Appendix 4C for the quarter ending 31st March 2020. The Company's cash plus term deposits at the end of the quarter stood at $3.3m.

Read Full Article